Open Access

Prognosis of segmentectomy in the treatment of stage IA non‑small cell lung cancer (Review)

  • Authors:
    • Wenliang Bai
    • Shanqing Li
  • View Affiliations

  • Published online on: November 25, 2020     https://doi.org/10.3892/ol.2020.12335
  • Article Number: 74
  • Copyright: © Bai et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

With improvements in detection technology, increasing numbers of patients with non‑small cell lung cancer (NSCLC) are being diagnosed at an early stage. In order to treat the illness with minimal invasion and preserve lung function to the greatest possible extent, there has been an increasing tendency towards treating early‑stage NSCLC by segmentectomy. However, questions remain regarding whether patients may benefit from this procedure considering the surgical and oncological outcomes. Whether adequate margin distance and lymph node dissection may be achieved is one of the most important issues associated with this procedure. The present study reviews the prognosis of segmentectomy in the treatment of stage IA NSCLC.
View References

Related Articles

Journal Cover

January-2021
Volume 21 Issue 1

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Bai W and Li S: Prognosis of segmentectomy in the treatment of stage IA non‑small cell lung cancer (Review). Oncol Lett 21: 74, 2021.
APA
Bai, W., & Li, S. (2021). Prognosis of segmentectomy in the treatment of stage IA non‑small cell lung cancer (Review). Oncology Letters, 21, 74. https://doi.org/10.3892/ol.2020.12335
MLA
Bai, W., Li, S."Prognosis of segmentectomy in the treatment of stage IA non‑small cell lung cancer (Review)". Oncology Letters 21.1 (2021): 74.
Chicago
Bai, W., Li, S."Prognosis of segmentectomy in the treatment of stage IA non‑small cell lung cancer (Review)". Oncology Letters 21, no. 1 (2021): 74. https://doi.org/10.3892/ol.2020.12335